NCT07160569View on ClinicalTrials.gov

Microbiological and Clinical Characteristics of Severe Infections Caused by Carbapenem-Resistant Enterobacterales

Not yet recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

July 1, 2026

Study Completion Date

August 31, 2026

Conditions
Carbapenem-Resistant Enterobacteriaceae Infection
Interventions
DIAGNOSTIC_TEST

Whole Genome Sequencing (WGS), Sequence Type Analysis (ST)

Whole Genome Sequencing (WGS), Sequence Type Analysis (ST), resistome, viruloma, and phenotypic resistance of CRE

Trial Locations (4)

00168

Fondazione Policlinico Universtiario Agostino Gemelli IRCCS, Rome

Unknown

"Unit of Infectious and Tropical Diseases, Azienda Ospedaliera Cannizzaro, Catania", Catania

"Unit of Infectious and Tropical Diseases, University Magna Graecia, Catanzaro", Catanzaro

"Unit of Infectious and Tropical Diseases, Azienda Ospedaliera Bianchi-Melacrino-Morelli, Reggio Calabria", Reggio Calabria

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

NCT07160569 - Microbiological and Clinical Characteristics of Severe Infections Caused by Carbapenem-Resistant Enterobacterales | Biotech Hunter | Biotech Hunter